{
  "ptid_time": "014_S_2308_2013-04-11",
  "img_path": "/data/qiuhui/data/adni/images/014_S_2308/2013-04-11/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 41,100 mm³, 6.7% above the reference mean. With a Z-score of 0.16 (56.4th percentile), this represents normal volume ; whole brain volume measures 915,835 mm³, 15.2% below the reference mean. With a Z-score of -1.97 (2.5th percentile), this represents moderate atrophy; entorhinal cortex volume measures 2,814 mm³, 31.4% below the reference mean. With a Z-score of -2.13 (1.7th percentile), this represents significant atrophy; fusiform gyrus volume measures 17,388 mm³, 7.7% below the reference mean. With a Z-score of -0.66 (25.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 21,287 mm³, 0.2% below the reference mean. With a Z-score of -0.02 (49.1th percentile), this represents normal volume . ",
  "text_data": "Age is 76.8 years. Gender is Male. Education: 15 years. MMSE: 30.0. MoCA: 26.0. Logical Memory: 16.0. APOEε4 alleles: 0.0. ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The patient shows moderate whole brain atrophy and significant entorhinal cortex atrophy, both of which are strongly associated with Alzheimer's disease. However, cognitive scores (MMSE 30, MoCA 26) are within normal limits, suggesting no significant functional impairment.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (due to structural atrophy without overt cognitive decline).  \n**Confidence:** **Medium** (high confidence in atrophy, but cognitive scores complicate the diagnosis).  \n\n*Note: The absence of APOE4 reduces genetic risk, but structural changes are concerning. Follow-up cognitive testing and biomarker analysis (e.g., CSF Aβ/tau or amyloid PET) would strengthen confidence.*",
  "timestamp": "2025-07-25T23:48:54.473605"
}